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The Sound of Silence:
Observational Learning in the U.S. Kidney Market
Abstract
Mere observation of others’ choices can be informative about product quality. This paper
develops an individual-level dynamic model of observational learning, and applies it to
a novel data set from the U.S. kidney market where transplant candidates on a waiting
list sequentially decide whether to accept a kidney offer. We find strong evidence of
observational learning: patients draw negative quality inferences from earlier refusals in
the queue, thus becoming more inclined towards refusal themselves. This self-reinforcing
chain of inferences lead to poor kidney utilization despite the continual shortage in kidney
supply. Counterfactual policy simulations show that patients would have made more
efficient use of kidneys had the concerns behind earlier refusals been shared. This study
yields a set of marketing implications. In particular, we show that observational learning
and information sharing shape consumer choices in markedly different ways. Optimal
marketing strategies should take into account on how consumers learn from others.
Keywords: observational learning; learning models; informational cascades; herding;
quality inference; Bayes’ rule; dynamic programming; kidney allocation
11 Introduction
Maciej Lampe declared for the NBA draft at the perfect time. He was the rarest com-
modity in an NBA draft—a tall, young, European big man with a sweet shooting stroke.
He was seen as raw but full of potential, which made him a top ten pick in most experts’
projections, and as high as number five overall (www.nba.com, June 27, 2003). Unfortu-
nately, on draft day, the Miami Heat passed on Lampe at number five, and the bad news
started to snowball (sports.ESPN.go.com, June 26, 2003). Teams grossly overestimated
the risks in investing a first round pick on Lampe, allowing him to slip all the way to
the second round, at number 30 overall. Subsequently playing in BC Khimki Moscow,
Lampe was awarded as the MVP in the Russian Cup final in February 2008.
Maciej Lampe is not alone. In labor markets, an episode of unemployment is known
to dampen the success of job search, beyond what is justified by the job candidate’s
qualification. In housing markets, skepticism accumulates around the value of a property
as its “time on market” increases, forcing some sellers to relist their properties to break
this chain of negative inferences. In general, people frequently engage in “observational
learning,” drawing quality inferences from mere observation of peer choices: Restaurants
that maintain a sizable waiting list are often perceived to be of high quality; book buyers
pursue bestsellers; internet surfers swarm high click-volume contents. Marketers too
have woken up to the prevalence of observational learning, and have created innovative
promotional tactics to harness its magic. For example, to introduce the T68i phones
to the U.S. in 2002, Sony Ericsson sent trained actresses to bars and lounges with the
phones, in hopes that onlookers would notice and believe that they stumbled onto a hot
new product (Wall Street Journal, July 31, 2002). The goal of this paper is to empirically
model observational learning behavior and its impact on choices.
It is challenging, however, to empirically identify the existence and isolate the impact
of observational learning. First, observation of choices often coexists with other sources
of quality information such as word-of-mouth communication (e.g. Ellison and Fuden-
berg 1995, Godes and Mayzlin 2004, Mayzlin 2006), payoff experiences (e.g., Nelson 1970,
Erdem and Keane 1996, Camerer and Ho 1999, Villas-Boas 2004 and 2006, Hitsch 2006,
Narayanan, Chintagunta and Miravete 2007), and the supplier’s selection of marketing
mix variables (e.g., Moorthy and Srinivasan 1995, Wernerfelt 1995, Desai 2000, Anderson
2and Simester 2001, Guo and Zhao 2008). Second, even in markets where observational
learning plays a dominant role, the choice dynamics are often complex. For example, a
potential restaurant patron may not know whether those waiting in line had all indepen-
dently chosen this restaurant, or some had been attracted by the line itself. Depending
on the construction of the choice sequence, the quality inference can be vastly different.
This paper meets these challenges by studying observational learning in perhaps its
cleanest environment—the U.S. market of transplant kidneys. When a deceased-donor
kidney is procured, compatible transplant candidates are sorted into a queue follow-
ing a nationally implemented priority system. The kidney travels down the queue until
a patient is willing to accept it for transplantation. It is ideal to study observational
learning in this kidney market for the following reasons. First, decisions are sequential,
and the sequence is constructed through a commonly known process. Second, privacy
concerns and the limited decision time minimize the chance for between-patient commu-
nication. Meanwhile, observational learning is fully enabled in that all previous decisions
are observable—the fact that a patient is offered a kidney unambiguously implies that all
preceding patients on the queue have turned down this kidney. Third, the kidney market
is unlikely to be influenced by other primary mechanisms behind uniform social behavior,
such as sanctions of deviants, preference for social identification (e.g., Kuksov 2007), and
network effects (e.g., Yang and Allenby 2003, Nair, Chintagunta and Dube´ 2004, Sun, Xie
and Cao 2004). In particular, kidneys do not contain the “public appearance value” that
partly explains the urge for possessing the right cell phone, choosing the right restaurant,
or sporting the right fashion gear.
This paper adopts a structural Bayesian approach to modeling observational learning.
While all patients on a queue observe the objective kidney quality measures (e.g., donor
age), each patient also receives a private quality signal (e.g., her physician’s recommen-
dation). If a kidney is passed on to the second patient, she knows that the first patient’s
private signal must have failed to reach a threshold determined by the first patient’s
utility function. The second patient can then apply Bayes’ rule to update her quality
perception of this kidney. Ceteris paribus, the first patient’s rejection decision lowers the
second patient’s perception of the kidney’s quality and hence her propensity to accept.
The second patient’s likely refusal in turn lowers the quality perception for subsequent
patients, triggering a herd of refusals down the queue. As a result, a kidney’s chance of
3acceptance critically depends on its choice history as well as its intrinsic quality.
There are several advantages to the structural modeling approach.1 The pioneering
works of Banerjee (1992) and Bikhchandani, Hirshleifer and Welch (1992) have theoret-
ically proven that observational learning may lead to informational cascades and herd
behavior, where individuals rationally ignore their private information and repeat their
predecessors’ actions. Empirically documenting observational learning therefore often re-
lies on evidence of convergence in actions (e.g., Anderson and Holt 1997, C¸elen and Kariv
2004).2 As the first study to structurally model observational learning at an individual
level, this paper does not require action convergence to identify observational learning.
In fact, by embedding sequential Bayesian updating in a choice model, we are able to
quantify the impact of observational learning from the continuous changes in posterior
valuation, which we recover from the discrete variation in observed choices. Furthermore,
this individual-level approach allows us to explicitly model how observational learning of
common values (such as kidney quality) is moderated by private values (such as patient-
donor tissue match). Last, the structural framework enables a set of policy experiments,
especially counterfactual comparison of an array of learning mechanisms.
The most common reason for patients to reject a kidney offer is that the kidney is
believed to be of marginal quality and that patients choose to wait for better kidneys
(United Network for Organ Sharing (UNOS) 2002 Annual Report). That is, kidney
adoption decisions involve dynamic tradeoff. For example, even if kidneys are believed to
be of poor quality when they reach the back of the queue, patients at the back of the queue
are also less likely to receive good kidneys in future. To model this inter-temporal tradeoff,
we cast quality learning in a dynamic choice setting where forward-looking patients seek
to maximize their expected discounted present value. This dynamic model allows us to
capture how patients’ decisions depend on the progression of their health conditions, their
chance of getting kidney offers in future, and the quality of these future kidney offers,
which in turn depends on other patients’ decision rule.
We find significant evidence of observational learning. At the first glance, even iden-
1Please see Chintagunta, Erdem, Rossi, and Wedel (2006) for discussion of the development and
application of structural models in marketing.
2Please see Bikhchandani, Hirshleifer and Welch (1998) for a review of the observational learning
literature.
4tical kidneys from the same donor are received much differently. While some kidneys
are accepted early on in the queue, their identical counterparts have to go far down the
line to find a transplant recipient. In other words, early rejections seem to considerably
influence subsequent decisions. After further controlling for patient-donor match, deteri-
oration of kidney quality when traveling down the line, patients’ option value of waiting,
and patients’ risk attitudes, model estimation confirms the significant impact of observa-
tional learning—on average, the further a kidney travels down the queue, the lower its
perceived quality. A competing explanation is that negative information about kidney
quality, although unobservable to the researcher, has lowered the acceptance propensity
of all patients. This explanation is modeled, estimated, and ruled out.
Another primary learning mechanism in social contexts is information sharing. Policy
permitting, a patient could have obtained private quality signals from her predecessors
who have evaluated and rejected the kidney. Observational learning and information
sharing have distinct choice implications. To see this, suppose a patient receives a fa-
vorable signal but decides to reject the kidney due to her higher standards. A unique
prediction of observational learning is that a rejection always (weakly) decreases subse-
quent patients’ quality perception. However, if this favorable private signal is shared with
subsequent patients, it may help them evaluate the kidney positively despite the rejection
decision. If the average of private signals reveals the true underlying value of a kidney,
when more signals aggregate, choices will converge to an efficient level. Indeed, policy
experiments show that patients would have made much more efficient decisions were they
able to communicate the reasons behind rejection decisions. This finding may help the
U.S. organ allocation system alleviate the urgent inefficiency problem, where “most of
the refused kidneys are of acceptable clinical value” despite the significant shortage of
transplant kidney supply (UNOS 2002 Annual Report).
An important message to marketers in general is that a product’s market performance
is more than a simple sum of sales. A small number of choices can be critical in deter-
mining product success, especially in categories with highly visible choices but limited
information sharing. Early adopters and marginal consumers are likely to be such piv-
otal influencers. Optimal marketing strategies should take into account whether and how
consumers learn from others.
5The rest of the paper is organized as follows. §2 overviews the U.S. kidney transplant
market and presents the data. §3 models three learning mechanisms—no social learning,
information sharing, and observational learning, and embeds these learning mechanisms
in a dynamic choice model of forward-looking patients. These models are estimated
in §4, where we find that the observational learning model explains the data best. A
competing model of public (i.e., available to all patients) quality information is ruled
out. §5 simulates and compares patient decisions under different learning mechanisms.
§6 discusses how the insights would apply to general markets. §7 concludes the paper
and suggests directions for future research.
2 The U.S. Kidney Market and Data
2.1 Overview of the U.S. Kidney Market
Each year more than 40,000 people in the United States develop end-stage renal diseases.
The two major treatments are dialysis and kidney transplantation. Dialysis requires at
least 9 to 12 hours of treatment at a dialysis center each week. Transplantation frees
patients from the inconveniences of dialysis and, if successful, offers a quality of life
comparable to one without kidney disease. Transplant kidneys come from either living
donors or deceased donors. While the former source is superior, the supply is limited
in the United States. As a result, more than half of donated kidneys are procured from
deceased donors.
Patients waiting for deceased-donor kidneys are placed on a waiting list administered
by the United Network for Organ Sharing (UNOS). When a kidney is procured, blood-
type compatible patients within the same organ procurement organization (OPO) are
sorted into a queue based on a UNOS point system. The Appendix provides details on
the queuing scheme, which is largely first-come-first-serve with local perturbations caused
by tissue match, high peak panel reactive antibody (PRA) measures, and juvenility.
The kidney is offered sequentially to patients in the queue until someone accepts it for
transplantation. During the search for transplant recipients, kidneys are kept frozen and
accumulate cold ischemia time. A long cold ischemia time may lead to inferior transplant
outcomes. Therefore, kidneys are normally discarded if not accepted within 48 hours.
6There has been an acute shortage of deceased-donor kidneys in the United States.
According to the 2006 Annual Report of the Organ Procurement and Transplantation
Network (OPTN), an organization administered by UNOS under contract with the U.S.
Department of Health and Human Services, 32,381 new end-stage renal diseases patients
in the U.S. joined the transplant waiting list in 2006, while only 10,659 deceased-donor
kidneys were transplanted in that year. Between 1992 and 2006, the number of people
on the national kidney waiting list grew from 22,063 to 65,199. Despite the short supply,
more than 10% of deceased-donor kidneys are discarded after being repeatedly refused by
transplant candidates. OPTN has identified the low kidney acceptance rate as a major
challenge to kidney allocation efficiency.
The alarming inefficiency of the current kidney allocation system has attracted sub-
stantial attention in academia. Studies suggest a number of solutions including paired
kidney exchange (e.g., Roth, So¨nmez, and U¨nver 2004) and restructuring the queuing
mechanism (e.g., Su and Zenios 2004). These studies have focused on system optimiza-
tion from the policy-maker’s perspective, and have left unexplored the micro-level patient
decision processes. While the most common reason for kidney refusal is that the current
offer is believed to be of marginal quality such that patients choose to wait for a better
kidney (UNOS 2002 Annual Report), it remains unknown how patients form this quality
perception. In fact, OPTN laments the fact that medical measures alone are insufficient
in predicting patient decisions:
“Although the effects of donor and recipient characteristics on kidney graft survival
have been documented, the relationship of these characteristics and center-specific
practices on organ acceptance rates is not well understood. We hypothesized that
variation in acceptance rates, beyond that which can be explained by recipient and
donor characteristics, exists among transplant programs, and that metrics could be
developed to quantify these behaviors.” (OPTN/SRTR 2006 Annual Report).
In this study, we investigate the underlying drivers of patient decisions, identify obser-
vational learning as an important factor behind the “variation in acceptance rates,” and
suggest policy changes to promote efficient kidney usage.
72.2 Data
The data set for this study combines the national waiting list data from the UNOS 2002
Annual Report and the transplant detail data from the United States Renal Data System
2001 Annual Report. All analyses focus on the TXGC OPO, a major OPO in Texas
and one of the largest OPOs in the United States. Kidneys of different blood types
normally enlist different queues of patients due to blood-type compatibility screening.
This paper presents the statistics for blood-type A kidneys. The resulting sample includes
338 patients and 275 accepted kidneys. Kidneys arrive at the OPO at an average rate of
one per six days, which does not vary significantly over time (p = 0.141). An observation
is defined as one decision occasion where a patient is presented with the choice of whether
to accept a kidney. The sample contains 9,384 observations.
Table 1 presents the summary statistics of three classes of variables in the data.
Patient-specific variables include patient age, gender, race, employment status, income,
PRA measure, and number of years on dialysis. Kidney-specific variables include donor
age, gender, race, and queue information (e.g., queue position of the accepting patient).3
The most important patient-kidney interactive variables are the tissue match measures.
The dummy variables “0 Mismatch,” “0 Mismatch at DR,” and “1 Mismatch at DR”
indicate perfect, second-best, and third-best tissue match respectively (see the Appendix
for details), where perfect tissue match occurs only 0.4% of the time. Another important
patient-kidney interactive factor is the cold ischemia time a kidney has accumulated when
offered to a patient. The quality of a kidney may deteriorate as its cold time increases.
Notably, only 2.9% of kidney offers are accepted. In this data, a kidney can be
accepted by as late as the 77th patient in the queue. On average, a kidney is accepted by
the 34th patient, who has already turned down 15 previous offers and has waited 209 days
at the time of acceptance. Figure 1 shows kidney acceptance rates across positions in the
queue. Approximately 10% of patients at the top of the queue accept the kidney offer.
Subsequent analyses reveal that this acceptance rate is largely explained by perfect tissue
match, which advances a patient to the top of the queue. Patients from position 2 to
3Other clinical measures include patient body surface area, dialysis modality, comorbidities, donor
body surface area, and cause of death. Inclusion of these clinical measures does not significantly alter
the estimation results.
8position 13 almost always reject the offer. The acceptance rate then increases moderately,
remains flat for most part of the queue, and rises sharply at the end. The larger variance
near the end of the queue results from a smaller number of observations falling in that
range: only 0.35% of observations fall beyond position 70.
Figure 1: Kidney Acceptance Rates across Queue Positions
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2.3 A First Evidence of Observational Learning: Acceptance of Same-Donor
Kidneys
A special feature of deceased-donor kidney donation is that sometimes both kidneys can
be retrieved from the same donor. Out of 275 kidneys in the sample, there are 58 pairs of
same-donor kidneys, each pair containing identical kidney-specific clinical measures and
therefore enlisting the same pool of eligible patients. If acceptance decisions are mainly
driven by these observable kidney and patient characteristics, same-donor kidneys should
exhibit close acceptance patterns.
To see if this is true, we separate the same-donor kidneys into two groups: Group
1 contains the 58 kidneys that are accepted earlier in the queue, and group 2 contains
their 58 identical counterparts. Figure 2 illustrates the divergence in acceptance patterns
between same-donor kidneys. The 58 pairs of same-donor kidneys are listed along the
horizontal axis, each pair adjacently placed. The vertical axis is the queue position of the
9accepting patient for each kidney. Even kidneys with identical clinical measures seem to
fare differently in their search for transplant recipients. On average, kidneys in group 1
are accepted by the 30th patient, while those in group 2 are accepted by the 45th patient.
The difference in the queue position of the accepting patient is significant (t = −4.212,
p = .000).
Figure 2: Divergence in Acceptance for Same-Donor Kidneys
0
0
10
20
30
40
50
60
70
80
Same−donor kidney pairs
Po
sit
io
n 
wh
en
 a
cc
ep
te
d
 
 
Group 1
Group 2
The distinct acceptance paths for same-donor kidneys suggest that patient decisions
may be systematically influenced by a force other than observable kidney and patient
characteristics. The data pattern is particularly suited to an observational learning ex-
planation: if patients infer inferior kidney quality from a rejection decision, refusals will
be self-reinforcing and will delay acceptance even further. This can be true even if a
patient turned down the kidney only due to momentary unavailability (which can be
modeled as an idiosyncratic utility shock). As an initial test of whether rejections are
self-reinforcing, we estimate a logit model where the dependent variable is whether each
patient accepts a kidney offer, and the independent variables include the number of times
the kidney has been rejected so far, as well as all observable patient and kidney charac-
teristics (including the kidney’s cold time). Consistent with the observational learning
hypothesis, the coefficient for the number of previous rejections is negative (−0.0138) and
10
significant (p = 0.000).4
In fact, an ideal way to identify observational learning in the field is to compare the
adoption paths of two identical products and test for path dependence. Same-donor
kidneys represent one of the few commodities that satisfy this identicalness condition
in naturally occurring markets, and their diverging acceptance paths serve as a first
evidence of observational learning. In the following sections, we model observational
learning, identify its existence, and quantify its impact on choices.
3 A Dynamic Choice Model
This section develops a choice model where patients engage in observational learning, and
compares it with two other learning mechanisms: learning from private signals (no social
learning), and learning through information sharing. These learning models are cast in
a dynamic setting where patients make optimal tradeoff between accepting the current
kidney and waiting for future kidneys, given forecast of their future states of being.
3.1 Patients’ Dynamic Optimization Problem
Consider a discrete-time infinite-horizon dynamic optimization problem where a patient
chooses whether to accept a kidney offer in order to maximize her expected present
discounted value.5 Let i index patients and t = 1, · · · ,∞ index the kidney arrival time.
We consider the Markov Perfect Equilibrium where patients’ decisions only rely on payoff-
relevant state variables. Let Sit be a vector of all these state variables that are payoff-
relevant to patient i at time t, and dit be the decision variable that equals 1 if patient i
accepts kidney t and 0 if she rejects this kidney offer.
Once she accepts a kidney, a patient moves to the absorbing state of transplanta-
tion and receives an expected utility of EU(Sit) which captures her expected present dis-
4Although identical kidneys typically have an identical set of eligible patients, those who accept one
kidney drop out of the queue for its identical counterpart that arrives later. The logit model including
all observable attributes helps to control for such changes in queue composition.
5Practically, either the patient or the doctor can make the acceptance decision. This distinction,
however, does not conceptually alter the model. Throughout the paper, we refer to the decision-maker
as the patient.
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counted post-transplant payoffs. If she turns down the kidney, she incurs one period’s cost
of waiting C(Sit). Let δ denote the discount factor, V (Sit) denote a patient’s maximum
expected present discounted value given her current state Sit, and P(Si,t+1|Sit, dit = 0)
denote the transition probability of patient i’s state from time t to t+1 given she rejects
kidney t. The Bellman equation for patient i’s dynamic optimization problem at time t
is:
V (Sit) = max{EU(Sit), −C(Sit) + δ
∫
Si,t+1
V (Si,t+1) P(Si,t+1|Sit, dit = 0) dSi,t+1} (3.1)
3.2 Utility Function and Quality Inference
3.2.1 Patients’ Utility Function
In this section, we specify the state variables contained in Sit and formulate EU(Sit), the
expected payoff from accepting a kidney offer. Let Uit(Sit) denote the utility for patient
i to accept the kidney arriving at time t:
Uit(Sit) = Xitβ + αθt − αρθ2t + it (3.2)
Xit is observable to both patient i and the econometrician, and contains a constant term,
the characteristics of patient i at time t, the attributes of kidney t, and the patient-
kidney match measures. β consists of the utility weight parameters associated with Xit.
6
Observable characteristics may not capture the kidney quality completely. Let θt represent
any unobservable (to both the patient and the econometrician) quality component of
kidney t, and let α be the associated utility weight. Note that since tissue match is the only
clinically significant “horizontal” match factor after blood-type compatibility screening
(Su, Zenios, and Chertow 2004), θt is conceptualized as a “vertical” quality component
that is of common interest to patients. Patients are allowed to be risk averse towards
quality uncertainty. Following Erdem and Keane (1996), we introduce the quadratic term
αρθ2t to capture patients’ risk attitudes, where the risk coefficient ρ is positive if and only
if the patient is risk averse. For example, if ρ is positive, a patient’s utility function will
be concave in unobservable kidney quality. Her utility derived from the mean value of
6To keep the model computationally tractable, we do not estimate “parameter heterogeneity” among
patients but rely on the individual-level data to capture observable “attribute heterogeneity”.
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unobservable kidney quality is thus greater than the mean of the utilities derived from all
possible values of unobservable kidney quality. Last, it denotes the idiosyncratic utility
shock encountered by patient i when evaluating kidney t. For example, a patient may
experience momentary inconveniences such as unfavorable physiological conditions which
prevent her from accepting instant transplant. Privately observed by patient i, it is
assumed to follow an i.i.d. Gumbel distribution across patients and across kidneys.
We assume that patients know the distribution of θt across kidneys, which is assumed
to be i.i.d. normal with mean µ and variance σ2θ :
θt ∼ N(µ, σ2θ) (3.3)
In addition, patient i receives a private signal sit of the unobservable quality θt. One
example of such private signal could be the physician’s quality judgment drawing upon her
expertise. Indeed, although organ sharing societies in the United States have published
certain policies guiding the kidney allocation process, they have also stated that “this
policy, however, does not nullify the physician’s responsibility to use appropriate medical
judgment”(UNOS 2002 Annual Report). Without actual data on the signal content, we
assume the private signals to follow a conditional i.i.d. normal distribution around θt,
although the model can be extended to incorporate alternative signal distributions.7 In
other words, although private signals vary across individuals, a large-sample average of
7The assumption that private signals are continuous allows for the possibility that physicians com-
municate a fine gradation of quality judgment. For example, physician recommendations may convey
various levels of preferences. Alternatively, physicians may recommend patients to either accept a kidney
or reject it. Such binary signals can be modeled as a discrete manifestation of physicians’ latent eval-
uation of the kidney. Correspondingly, in the learning models presented in this paper, the conditional
probability of continuous signals given kidney quality is replaced by the conditional tail probability that
a physician’s latent evaluation exceeds or falls below her recommendation threshold given kidney quality.
The essence of Bayesian inferences underlying the learning models remains the same.
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these signals would be an unbiased indicator of the true quality:8
sit|θt ∼ N(θt, σ2s) (3.4)
As will be discussed later, α, σθ and σs cannot all be identified. However, we will keep
the notation separate throughout to trace the different role each parameter plays in the
learning process.
A patient’s inferred value of θt varies with the information accessible to her. In the
rest of this section, we model and compare this quality inference process corresponding
to three representative information structures: (1) no social learning, where a patient
updates her quality perception based on her knowledge of the prior distribution of θt
and her private signal sit; (2) social learning through information sharing, where in addi-
tion to the prior distribution and her own signal, a patient also acquires other patients’
private signals through, for example, truthful word-of-mouth communication; and (3) ob-
servational learning, where besides the prior distribution and the patient’s private signal,
others’ choice decisions contain information about the unobservable quality. Let Iit be
the set of aforementioned information that helps patient i infer the value of θt. Let Oit be
a dummy variable that equals 1 if patient i is offered a kidney at time t and 0 otherwise.
Lastly, let Zit denote patient characteristics that affect their cost of waiting. Zit will be
operationalized in §3.4. Patient i’s state variables at time t are therefore decomposed as
follows:
Sit = {Oit, Xit, Zit, Iit, it} (3.5)
The expected payoff for patient i to accept kidney t is
EU(Sit) = E(Uit|Sit) = Xitβ + αE(θt|Iit)− αρE(θ2t |Iit) + it, if Oit = 1 (3.6)
8The variance of the private signals σ2s may in theory change across kidney episodes. For example, by
evaluating kidneys repeatedly, a doctor’s precision in judgment may improve over time. To explore this
possibility, we stratify the sample into two subsamples based on a median split of the number of previous
offers a patient has received until her current decision. We estimate the model allowing the signal variance
for “experienced” patients (σ2se) and “inexperienced” patients (σ
2
si) to be different. The likelihood-ratio
test fails to reject the null hypothesis that σse = σsi (χ2(1) = 0.398, p = 0.528). In addition, it is
possible that unobservable quality and therefore private signals are correlated across identical kidneys
from the same donor. In the estimation we report, unobservable quality and private signals are treated
as independent across identical kidneys. A robustness check restricting unobservable quality and private
signals to be the same for identical kidneys yields close estimation results.
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where E(θ2t |Iit) can be decomposed as E(θt|Iit)2+E[(θt−E(θt|Iit))2|Iit]. Therefore, calcu-
lating EU(Sit) boils down to inferring the posterior distribution of θt given Iit, which will
be modeled in the rest of this section. To complete the utility specification, we normalize
the deterministic part of patient i’s expected payoff to 0 when she does not receive a
kidney offer. That is,
EU(Sit) = it, if Oit = 0 (3.7)
3.2.2 Quality Inference without Social Learning
A patient’s expected value of the unobservable quality θt is equal to the prior mean µ
if all she knows is the prior distribution of θt. However, she can fine-tune her quality
perception if she also receives a private signal. By Bayes’ rule (DeGroot 1970), the
posterior expectation of θt is a weighted average of the prior mean µ and the private
signal:
E(θt|Iit) = σ
2
θsit + σ
2
sµ
σ2θ + σ
2
s
, Iit = {sit} (3.8)
Intuitively, the less accurate the private signal is, the more weight is assigned to the prior
quality perception.
3.2.3 Quality Inference through Information Sharing
A patient can further update her quality perception when she engages in social learning
and obtains private signals from other decision-makers.9 Let rit denote patient i’s position
in the queue for kidney t. For simplicity of presentation, we drop the subscript it. Suppose
a patient acquires private signals from all her r−1 predecessors, the posterior expectation
of θt is a weighted average of the prior mean µ and the sample average of these r signals:
E(θt|Iit) =
σ2θ
∑r
j=1 sjt + σ
2
sµ
r · σ2θ + σ2s
, Iit = {s1t, · · · , srt} (3.9)
The weight given to the prior decreases in r. That is, the more doctors a patient consults,
the more likely it is for her to trust the consensus. An analogy in new product diffusion is
9We assume truthful sharing of signals. However, this model can be extended to capture untruthful
communication if we can specify a structure for any signal distortion.
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that while innovators rely more on their prior quality knowledge, imitators may pay more
attention to product reviews. When r approaches infinity, the posterior expectation of θt
equals the average of all observed signals which, by the law of large numbers, approaches
the true value of θt. This convergence property is consistent with the common notion of
“the wisdom of crowds.”
Note that although patients can also share other information such as decisions, in this
setup only private signals matter to subsequent patients. Once a patient shares her signal,
her actual choice does not add information regarding the quality of this particular kidney.
It is possible though that a patients learns more about her predecessors by watching their
decisions, in which case previous decisions should be part of the information set. Such
dynamics are interesting to model in future research.
3.2.4 Information Sharing vs. Observational Learning
When communication is costly and others’ private signals unaccessible, mere observations
of others’ actual choices can be informative too. Before presenting the observational learn-
ing model, we first intuitively describe two key differences between (truthful) information
sharing and observational learning.
First, with information sharing, a rejection does not always lower expected quality
perceived by subsequent decision-makers. To see this, suppose the second patient is
offered a kidney. If the first patient does receive a good signal but rejects the kidney due to
poor tissue match, information sharing may actually increase the second patient’s inferred
quality. With observational learning, however, the second patient’s inferred quality can
only be lowered by the first patient’s rejection. This is because the first patient is more
likely to reject the kidney with worse private signals, which are more likely to occur with
worse kidneys. The second patient would therefore assign higher probabilities to low
kidney qualities by Bayes’ rule. Property 3 in the next section states this result formally.
Second, with information sharing, previous signals enter a patient’s quality evaluation
continuously (Equation 3.9). Therefore, extreme values of private signals are diluted in
a large sample, eliminating the existence of “pivotal” patients. In contrast, marginal
patients can be crucial in shaping subsequent choices with observational learning. This
is because a patient’s quality inference is discontinuous in her predecessors’ signals under
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observational learning due to the discrete nature of choices. To see this, suppose patient
one is on the margin but chooses acceptance over rejection. Patient two would then infer
that patient one’s private signal must have been “favorable enough.” Suppose alterna-
tively that patient one receives an infinitesimal negative perturbation in her private signal
and therefore marginally prefers rejection. This new decision only changes patient one’s
own utility infinitesimally. However, patient two’s inferred region of the first signal now
becomes the lower tail of the distribution, which decreases patient two’s quality expecta-
tion discontinuously. If patient two in turn switches to rejection, patient one’s marginal
decrease in private signals can be amplified into chain of rejections down the queue.
These fundamental differences lead to the prediction that choices are ultimately driven
by quality with information sharing, but are sensitive to initial choices and marginal
choices with observational learning. In the kidney market, the queue ends whenever
the kidney is accepted. Therefore, observational learning is asymmetrical in the sense
that only observations of rejections influence subsequent patients. Such a market is
likely to generate excessive rejections. In the following sections we model observational
learning and explore whether it indeed triggers excessive rejections of kidneys. In §6 we
discuss a set of aggregate predictions that distinguish between information sharing and
observational learning in general markets.
3.2.5 Quality Inference through Observational Learning
In this section, we formally model quality inferences when a patient observes all her
predecessors’ decisions, but does not know the precise reason behind each decision. The
information set for patient in position r becomes Iit = {d1t, · · · , dr−1,t, srt}. In the kidney
market, the fact that the patient in position r is offered the kidney implies that {d1t =
· · · = dr−1,t = 0}. However, the model below can be extended to accommodate a generic
permutation of acceptance/rejection decisions in the sequence, and apply to other markets
where a product can be accepted by multiple consumers.
The First Patient
The first patient decides whether to accept kidney t based on her own signal s1t. Her
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posterior expectation of θt is
E(θt|s1t) = σ
2
θs1t + σ
2
sµ
σ2θ + σ
2
s
Note that the expected utility from accepting the kidney increases with the private signal
s1t. At the same time, a patient’s current private signal does not affect the utility she
can derive from accepting a future kidney offer. This is because private signals are drawn
independently around the true unobservable quality (by Assumption 3.4), which in turn
is drawn from an independent pool (by Assumption 3.3). Therefore, the first patient
accepts kidney t if and only if s1t ≥ B1t, where B1t is the cutoff signal that solves the
indifference condition:
EU(S1t) = −C(S1t) + δ
∫
S1,t+1
V (S1,t+1) P(S1,t+1|S1t, d1t = 0) dS1,t+1
with EU(S1t) given by Equation 3.6.
The Second Patient
The second patient infers θt based on two pieces of information: the rejection decision
of the first person d1t = 0, and her private signal s2t. By Bayes’ Rule, the posterior density
of θt is proportional to the product of the conditional (on θt) density of the observed data
and the prior density of θt:
p(θt|d1t = 0, s2t) ∝ p(d1t = 0, s2t|θt) · p(θt)
The first patient’s cutoff B1t determines the informativeness of her decision. However,
B1t is not directly observed by the second patient. For example, she does not observe
whether the first patient has turned down the kidney due to poor tissue match or despite
good match, even though the quality implications are vastly different. Fortunately, the
nationally publicized queuing policies provide patients with “distributional” knowledge
of the queue. In fact, a patient is often on a queue with the same set of peer patients.
For instance, patients would know that the top of the queue tends to be associated with
better tissue match and longer waiting time. Therefore, we assume the second and all
subsequent patients to know the distribution of B1t, denoted as G(B1t). One sufficient
condition for this assumption to hold is common knowledge of the distribution of patient
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and kidney attributes among the first patients in the line, of the distribution of patients’
idiosyncratic utility, and of the transition probability P( · | · ). It follows that
p(d1t = 0, s2t|θt) =
∫
p(s1t < B1t, s2t|θt) dG(B1t)
Since the private signals s1t and s2t are conditionally (on θt) independent, the condi-
tional probability of the joint event that the first signal is below B1t and the second event
equals s2t is the product of the conditional probabilities of these two events:
p(s1t < B1t, s2t|θt) = p(s1t < B1t|θt) p(s2t|θt) = Φ(B1t − θt
σs
) φ(
s2t − θt
σs
)
where Φ(·) and φ(·) are the c.d.f. and p.d.f. of the standard normal distribution respec-
tively. Consequently, the posterior density of θt can be written as
p(θt|d1t = 0, s2t) ∝ φ(s2t − θt
σs
) φ(
θt − µ
σθ
)
∫
Φ(
B1t − θt
σs
) dG(B1t) (3.10)
The second patient’s posterior expectation of quality θt is
E(θt|d1t = 0, s2t) =
∫
p(θt|d1t = 0, s2t) θt dθt∫
p(θt|d1t = 0, s2t) dθt
where the denominator serves as a normalizing factor to ensure that the posterior density
of θt integrates to one.
Other things being equal, the higher s2t, and the lower G(B1t) in the sense of first-
order stochastic dominance, the higher the second patient’s expected quality of kidney t.
This can be seen from equation 3.10: both a larger B1t and a larger s2t shift more weight
to θt values towards the upper tail of its posterior distribution. The intuition is that the
second patient will infer higher kidney quality when she receives a more favorable private
signal, and when she knows that the first patient rejected the kidney only due to her high
standards. Since E(θt|d1t = 0, s2t) increases in s2t, the second patient’s decision rule can
also be characterized by a cutoff strategy. She accepts the kidney if and only if s2t ≥ B2t,
where B2t is the private signal value that makes her just indifferent between acceptance
and rejection:
EU(S2t) = −C(S2t) + δ
∫
S2,t+1
V (S2,t+1) P(S2,t+1|S2t, d2t = 0) dS2,t+1
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A Generic Patient
The third patient draws quality inference in the same way as the second patient,
knowing that the second patient’s rejection decision had been partially triggered by the
first patient’s rejection. In general, after observing r− 1 previous rejection decisions and
her own signal, patient r’s posterior expected value of θt is
E(θt|d1t = · · · = dr−1,t = 0, srt) =
∫
p(θt|d1t = · · · = dr−1,t = 0, srt) θt dθt∫
p(θt|d1t = · · · = dr−1,t = 0, srt) dθt (3.11)
where
p(θt|d1t = · · · = dr−1,t = 0, srt) =
φ( srt−θt
σs
) φ( θt−µ
σθ
)
∫ · · · ∫ ∏r−1j=1 Φ(Bjt−θtσs )dG(B1t, · · · , Br−1,t) (3.12)
The patient in position r accepts kidney t if and only if srt ≥ Brt, where Brt solves
the indifference condition
EU(Srt) = −C(Srt) + δ
∫
Sr,t+1
V (Sr,t+1) P(Sr,t+1|Srt, drt = 0) dSr,t+1 (3.13)
The posterior expected quality has a set of clean properties. For simplicity of presen-
tation, let hrt = E(θt|d1t = · · · = dr−1,t = 0, srt) represent the posterior expected quality
from observational learning:
Property 1 The higher a patient’s private signal, the higher her expected quality: ∂hrt
∂srt
>
0.
Property 2 The higher previous patients’ acceptance standard, the higher the expected
quality: Let G and G′ be any two cumulative distribution functions of previous patients’
acceptance standards. hrt(G) > hrt(G
′) if G first-order stochastically dominates G′.
Property 3 Other things being equal, a rejection decision always (weakly) decreases sub-
sequent patients’ expected quality: If srt = sr+1,t, then drt = 0 ⇒ hr+1,t ≤ hrt.
Properties 1 and 2 can be shown in the same way as for the second patient. To
see why Property 3 holds, notice from Equation 3.12 that when srt = sr+1,t, p(θt|d1t =
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· · · = dr,t = 0, sr+1,t) differs from p(θt|d1t = · · · = dr−1,t = 0, srt) in the integrand by
Φ(Brt−θt
σs
), which gives more weight to lower values of θt for any Brt < ∞. Therefore,
hr+1,t is lower than or equal to hrt when patient r rejects kidney t. Intuitively, if both
patients have witnessed the r − 1 previous decisions, the additional rejection decision
seen by patient r + 1 can only (weakly) decrease her expected quality of the kidney
unless she receives a sufficiently favorable private signal. It can be similarly shown that,
other things being equal, an acceptance decision always (weakly) increases subsequent
decision-makers’ expected quality.
Note that Property 3 pertains to contexts such as the kidney market where match-
related attributes (in particular, tissue type) are observable to patients. Property 3 may
not hold if choices are driven by match and if match attributes are yet to be learned.
For example, suppose two decision-makers are known to have opposite taste preferences.
One person’s rejection signals that the product is more likely to match the other person’s
tastes. In those scenarios, rejection may subsequently spur more acceptance.
It can be seen from the derivation so far that patients’ inter-temporal tradeoff affects
kidney adoption in at least two ways. A patient’s option value of waiting depends on her
chance of receiving future kidney offers and the quality of these kidneys. Meanwhile, the
same patient’s quality perception of the current kidney offer depends on the acceptance
standards of her predecessors, which in turn depend on their forecast of the future. To
precisely model the dynamics, next we develop the transition probability of patients’
dynamic optimization problem.
3.3 Transition Probability
The overall transition probability of patients’ dynamic optimization problem is decom-
posed as P(Si,t+1|Sit, dit = 0) = P(Oi,t+1, Xi,t+1, Zi,t+1, Ii,t+1, i,t+1|Oit, Xit, Zit, Iit, it, dit =
0). The following three features of the state space help simplify this transition probability.
First, since the idiosyncratic utility it is i.i.d. across both patients and time, it is
exogenous to the choice variable and orthogonal to all other state variables. Therefore,
its transition is independent of the transition of all other state variables: P(Si,t+1|Sit, dit =
0) = P(i,t+1) · P(Oi,t+1, Xi,t+1, Zi,t+1, Ii,t+1|Oit, Xit, Zit, Iit, dit = 0).
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Second, since private signals are drawn from an i.i.d. distribution around θt, which in
turn is distributed independently over time, private signals are uncorrelated over time.
Therefore, without social learning Ii,t+1 is independent of Iit. With information sharing,
Iit contains rit private signals. With observational learning, Iit contains rit − 1 rejections
and one private signal. Therefore, for both information sharing and observational learn-
ing, given Oi,t+1, the statistical dependence between Ii,t+1 and Iit is transmitted entirely
through the statistical dependence between ri,t+1 and rit: P(Oi,t+1, Xi,t+1, Zi,t+1, Ii,t+1|Oit, Xit, Zit, Iit, dit =
0) = P(Oi,t+1, Xi,t+1, Zi,t+1, si,t+1, ri,t+1| Oit, Xit, Zit, rit, dit = 0).
Third, the current offer status Oit and the current decision dit do not affect Xi,t+1
or Zi,t+1, which contains exogenous variables. Neither do they affect si,t+1, which will
be independently redrawn in period t + 1. In addition, since the UNOS priority system
does not punish kidney refusals, future queue position ri,t+1 does not depend on Oit or
dit. Last, the chance for patient i to receive a kidney offer in period t + 1 is sufficiently
determined by Xi,t+1, Zi,t+1 and ri,t+1, and does not directly rely on her state or deci-
sion at time t. Altogether, P(Oi,t+1, Xi,t+1, Zi,t+1, si,t+1, ri,t+1|Oit, Xit, Zit, rit, dit = 0) =
P(Oi,t+1, si,t+1|Xi,t+1, Zi,t+1, ri,t+1) · P(Xi,t+1, Zi,t+1, ri,t+1|Xit, Zit, rit).
In combination, the overall transition probability of the state space can be written as
P(Si,t+1|Sit, dit = 0) =
P(i,t+1) · P(Oi,t+1, si,t+1|Xi,t+1, Zi,t+1, ri,t+1) · P(Xi,t+1, Zi,t+1, ri,t+1|Xit, Zit, rit)
(3.14)
The first component P(i,t+1) is simply the p.d.f. of the Gumbel distribution. The
second component depends on individual equilibrium choice probabilities, which will be
developed in Section 3.4. The last component can be estimated from the data (see the
Online Appendix for details).
3.4 Choice Probabilities
Assume a patient’s cost of waiting is determined by her current state and an idiosyncratic
utility shock iot. That is
C(Sit) = Zitγ + iot, Zit ⊆ Sit (3.15)
where Zit contains patient i’s number of years on dialysis, income, and employment status.
These variables may affect the patient’s health status and well-being while waiting, and
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capture her opportunity cost of time.10
Given the i.i.d. Gumbel assumption of the idiosyncratic utility shocks, the probability
of patient i accepting kidney t given her current state is
Pr(dit = 1|Sit) = e
EU(Sit)
eEU(Sit) + e−C(Sit)+δ
R
V (Si,t+1) P(Si,t+1|Sit,dit=0) dSi,t+1 (3.16)
Data on patients’ private signals, such as the physician’s recommendations, would be
ideal to have but is often unavailable to the researcher. To circumvent this problem, the
private signals are integrated out to evaluate the acceptance probabilities of a kidney.
Given quality θt, signals about kidney t are conditionally independent, so are patients’
acceptance probabilities for kidney t. Denote as Pr(Rt|θt) the conditional probability
that kidney t of true unobservable quality θt is accepted by the patient in position Rt:
Pr(Rt|θt) =
Rt−1∏
i=1
∫
Pr(dit = 0|Sit)φ(sit − θt
σs
)dsit
∫
Pr(dRt,t = 1|SRt,t)φ(
sRt,t − θt
σs
)dsRt,t(3.17)
where Pr(dit = 0|Sit) = 1− Pr(dit = 1|Sit).
Meanwhile, neither the patients nor the researcher knows the true unobservable quality
θt. Therefore, the unconditional probability of kidney t being accepted at position Rt is
Pr(Rt) =
∫
Pr(Rt|θt) φ(θt − µ
σθ
) dθt (3.18)
It remains to develop the second probability component on the right-hand side of
equation 3.14. Assume patients have rational expectations so that P(Oit, sit|Xit, Zit, rit)
equals the equilibrium joint probability for the patient in position rit to reach an offer
status Oit and to receive a private signal sit. Importantly, the chance of being offered
a kidney and the chance of receiving signal sit are correlated through the unobservable
quality θt:
P(Oit = 1, sit|Xit, Zit, rit) =∫
[
∏rit−1
j=1
∫
Pr(djt = 0|Sjt) φ( sjt−θtσs )dsjt]φ( sit−θtσs )φ(
θt−µ
σθ
) dθt
(3.19)
Also, the higher the unobservable quality of the kidney, the less likely that the kidney
will reach a patient far down the queue. This idea is captured by a patient’s probability
10Inclusion of other patient characteristics as waiting cost determinants does not change the estimation
results qualitatively.
23
of not receiving a kidney offer:
P(Oit = 0|Xit, Zit, rit) =∫
[1−∏rit−1j=1 ∫ Pr(djt = 0|Sjt) φ( sjt−θtσs )dsjt]φ( θt−µσθ ) dθt (3.20)
4 Model Estimation
4.1 Estimation Procedure
The dynamic choice model is estimated using the nested fixed point algorithm (Rust
1987). For each set of parameter values, an “inner” algorithm computes the value function
and evaluates the likelihood function. An “outer” algorithm then searches for the set of
parameters that maximize the likelihood function.
4.1.1 Computing the Value Function
Let EV (Sit) denote the total future discounted value patient i expects to receive when
she turns down kidney t. That is,
EV (Sit) =
∫
Si,t+1
V (Si,t+1) P(Si,t+1|Sit, dit = 0) dSi,t+1 (4.1)
The Bellman’s equation becomes V (Sit) = max{EU(Sit), −C(Sit) + δEV (Sit)} accord-
ingly. Given the i.i.d. Gumbel assumption of the idiosyncratic utility shocks, EV (Sit) can
be rewritten as (Rust 1987):
EV (Sit) =
∫
Si,t+1
ln[eEU(Si,t+1) + e−C(Si,t+1)+δEV (Si,t+1)] P(Si,t+1|Sit, dit = 0) dSi,t+1 (4.2)
As discussed in the Online Appendix, the state space relevant to solving EV (·) is
discrete and can be much simplified thanks to the high degree of independence among
the state variables in this data. Let K denote the dimension of the state space, and Π
a K ×K Markov transition matrix in which the (r, c) element represents the transition
probability from state r to state c. (Please see the Online Appendix for the construction
of Π.) The discrete representation of the value function becomes
EV (·) = Π · ln[eEU(·) + e−C(·)+δEV (·)] (4.3)
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where EV (·), EU(·), and C(·) are allK×1 vectors with the rth element being the function
value evaluated at the rth state. The value function EV (·) is then solved iteratively using
standard fixed point algorithms.
4.1.2 Evaluating the Log-likelihood Function
Given EV (·) for each state, the choice probability in Equation 3.16 can be rewritten as
Pr(dit = 1|Sit) = e
EU(Sit)
eEU(Sit) + e−C(Sit)+δEV (Sit)
The probability of kidney t being accepted in position Rt, Pr(Rt), thus follows as given
by Equation 3.18. Note that the value function and these probabilities are derived for
a given set of parameters. Let ∆ denote the parameter vector to be estimated. The
log-likelihood associated with kidney t is a function of ∆:
LLt(∆) = lnPr(Rt|∆) (4.4)
Last, let T denote the total number of kidneys offered in the sample, the log-likelihood
function for the entire sample is
LL(∆) =
T∑
t=1
LLt(∆) (4.5)
The log-likelihood function includes high dimensional integrals, and is evaluated us-
ing the simulated maximum likelihood method. (Please see the Appendix for detailed
procedures to formulate the simulated likelihood function.)
4.2 Identification
Parameter Identification: To summarize, the parameters to estimate include patients’
utility weights associated with the patient and/or kidney characteristics that determine
the utility from accepting the kidney offer (β), patients’ utility weights associated with
the cost of waiting (γ), patients’ utility weight associated with the unobservable quality
(α), patients’ risk aversion coefficient (ρ), the prior mean of the unobservable kidney
quality (µ), the prior standard deviation of the unobservable kidney quality (σθ), the
standard deviation of the private signals (σs), and the discount factor (δ).
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The utility weight parameters β and γ are identified from the exogenous variation in
patient, kidney, and patient-kidney interactive characteristics. α is identified from the
systematic variation in choice decisions after the observable patient/kidney characteristics
are controlled for. The identification of ρ relies on the functional form restrictions in the
model: by assuming a functional form for the prior unobservable quality distribution and
for the conditional signal distribution, we are able to specify the posterior variance in the
unobservable quality, and isolate the effect of ρ from the magnitude of the impact of this
posterior variance on risk-adjusted preferences (see also Coscelli and Shum 2004).
The parameters µ, σθ, and σs together shape the learning process. The prior mean
µ affects the choices among patients on the top of the queue who do not engage in
observational learning. However, since Xit includes a constant term, the intercept term
in β cannot be separately identified from µ. We set µ to zero. The idea is to capture the
fixed value of transplantation through the intercept and to measure the mean value of
a particular kidney from the other observable attributes, with the unobservable quality
adding fluctuations around this mean. Note that α, σθ and σs cannot be all identified
simultaneously. The intuition is that the relative precision of prior quality and signals
determines the shape of the learning path, while α captures the remaining scaling effect.
Therefore, we restrict σθ to be 1 and estimate α and σs as free parameters.
Last, we fix the value of δ at 0.95 due to the usual difficulties in estimating the discount
factor in forward-looking dynamic models (see Erdem and Keane 1996). Altogether, the
set of parameters to be estimated are ∆ = {β, γ, α, ρ, σs}.
Observational Learning and Queue Position: Since the amount of (negative) obser-
vational learning monotonically increases down the queue, it is crucial to isolate observa-
tional learning from other queue-position-related factors. We try to keep the identification
of observational learning clean in the following ways. First, the same kidney may be of
different quality when it reaches the 30th patient than when it was with the 1st patient.
We capture this within-kidney quality variation across positions by the “cold time” vari-
able, which measures the time from when a kidney was retrieved from the donor until
when it reaches the patient. Second, queue position is completely determined by a set
of exogenous variables, which are observable to the econometrician and are controlled for
in the analyses. Third, due to the queuing policy, a patient’s queue position fluctuates
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across kidney episodes. This variation enables us to observe choices of the same patient
with different amounts of observational learning, and thus separately identify observa-
tional learning from patient-specific heterogeneity. Fourth, as information accumulates
along the queue, the precision of the posterior quality varies across queue position. This
may create additional cross-position variation in utilities if patients are not risk neutral.
We capture this variance by adding a flexible risk adjustment component in the utility
specification. Last, patients in different positions of the queue may have systematically
different prospects of future kidney offers. Modeling patients’ dynamic tradeoff helps to
rule out potential confounds from the inter-temporal dimension.
4.3 Alternative Models
In addition to observational learning, we specify four alternative models, each corre-
sponding to a different behavioral account of patients’ decision making processes. All five
models are embedded in the dynamic choice setting.
No Quality Uncertainty: In this basic model, patients make decisions based on observ-
able attributes only, either because quality is fully certain, or because quality uncertainty
does not affect their utilities. This is equivalent to restricting α in the full observational
learning model to 0. As a result, σs and ρ cannot be identified in this model.
Public Quality Information: Causality claims for socially correlated choices demand
extra caution (see Manski 1993). If there exist common contextual factors which the
econometrician neither observes nor accounts for, choice conformity can be spuriously at-
tributed to social contagion.11 For example, Van den Bulte and Lilien (2001) re-analyze
the classic diffusion study Medical Innovation (Coleman, Katz, and Menzel 1966) and
discover that the adoption of tetracycline turns out to be driven by marketing efforts
rather than social contagion as previously speculated. Manchanda, Xie and Youn (2008)
separate the effects of marketing communication and interpersonal communication, and
find that both affect adoption. In the NBA draft example at the start of the paper,
inferences could coexist with rumors about the player’s caliber that spread among teams.
In our data, one major competing explanation for repeated kidney refusals is the exis-
11See Villas-Boas and Winer (1999) for a general discussion of how the correlation between independent
variables and the error term can bias parameter estimates in choice models.
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tence of (negative) kidney quality information which is publicly known to patients but is
unobserved by the researcher. This competing explanation can be modeled by restricting
σs to 0 in the full observational learning model. It follows that θt represents the public
quality information unobserved by the researcher, and the model essentially becomes one
with random kidney effects. Therefore, given the functional form assumption, the test
between public quality information and observational learning becomes the parameter
test of whether σs = 0. Note that since there is no quality uncertainty, ρ is not identified
in this model.
No Observational Learning: In this competing account of the decision process, pa-
tients ignore previous rejections and infer kidney quality using the prior and their private
signal only as if they were the first in the queue, as specified in Equation 3.8. Note that
since every patient updates the prior only once, the variance of the posterior is identical
across patients. Therefore, the risk adjustment in the acceptance utility cannot be iden-
tified separately from the intercept. We do not estimate ρ as a free parameter but fix its
value at 0.
Information Sharing: Although information sharing does not exist in the data by
institutional design, we estimate this model for comparison purpose. The quality updating
rule is specified in Equation 3.9.
4.4 Estimation Results
4.4.1 Goodness of Fit and Model Selection
Table 2 reports the parameter estimates and model fit statistics of the observational
learning model and the four alternative models. Observational learning fits the data best
with the highest log-likelihood. In particular, the nested models “no quality uncertainty”
and “public information” are both rejected (likelihood-ratio statistic = 31.602, p = 0.000;
likelihood-ratio statistic = 27.164, p = 0.000 respectively). Indeed, the estimate of α
in the observational learning model differs from 0 at the p = 0.000 level, which means
that uncertain kidney quality does affect patients’ decisions. The estimated σs in the
observational-learning model is also significantly different from 0 (p = 0.000), which rules
out the competing explanation of public kidney quality information, given the functional
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form assumption.
The “no social learning” and “information sharing” models are not nested models
of observational learning. The Akaike information criterion (AIC) selects observational
learning as the best model. In fact, due to the significant signal variance, quality in-
ference by simply observing one’s own signal is noisy, which necessitates social learning.
The information sharing model fits better than no social learning. Note that information
sharing does not exist in the data. The better fit comes from the additional risk com-
ponent; because the posterior variance under information sharing declines with queue
position and because the corresponding risk coefficient is negative (meaning patients are
risk seeking by definition), other things being equal, the back of the queue would have
lower acceptance utility—a pattern in the same direction of observational learning. The
estimated utility weight associated with the unobservable quality, α, is more significant
in the observational learning model than in the alternative models. One explanation is
that since the quality inference processes specified in the observational learning model is
more consistent with the data, it assumes higher explanatory power.
4.4.2 Parameter Estimates
All five models yield similar parameter estimates for the observable attributes. In par-
ticular, older patients are more likely to accept a kidney offer. There is no significant
effect of patient’s number of years on dialysis, which is included to control for medi-
cal urgency, need for transplant, and dialysis-induced status quo bias. As expected, good
tissue match increases the acceptance propensity; perfect issue match increases it dramat-
ically. Interestingly, a longer cold time is associated with higher acceptance rates across
all models. This coefficient should better be interpreted as a correlation rather than a
causal effect. One possibility is that patients take longer time to evaluate “marginally
acceptable” kidneys, but are able to reject obviously poor kidneys immediately. Con-
sistent with this interpretation, cold time and queue position are negatively correlated
(correlation coefficient = −0.127, p = 0.035).
Figure 3 illustrates at the micro level how inferred quality changes along the queue.
For illustrative purpose, we take one representative kidney, fix unobservable quality at
zero, draw random signals and calculate each patient’s inferred unobservable quality us-
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ing the parameters estimates from the observational learning model. In the absence of
social learning, inferred unobservable quality fluctuates with private signals, but shows a
smaller variance due to the stickiness of the prior quality perception. With information
sharing, inferred unobservable quality quickly converges to the true value. With observa-
tional learning, inferred unobservable quality still responds to private signals, but declines
noticeably towards the end of the queue.
Figure 4 shows the impact of observational learning at the aggregate level. It plots
the average inferred unobservable quality across queue position. As expected, overall
the inferred quality declines down the queue, as doubts about quality accumulate with
repeated refusals. Interestingly, the shape of patients’ inferred quality curve shows how
heterogeneity in acceptance standards create heterogeneity in the pace of learning. Among
patients at the top of the queue, 10.91% have perfect tissue match, compared to 0.35%
across all patients. A rejection in spite of perfect match contains a strongly negative
message, lowering the inferred quality significantly from position 1 to position 2. After
that inferences slow down. This is because patients near the top of the queue tend to have
longer waiting time, and are likely to keep their priority in the queue at the next offer.
Therefore, they can afford to wait for the “ideal kidney,” and their refusal reveals little
information about their private signals. This is consistent with the fact that patients in
positions 2 to 12 almost always reject (see Figure 1). Moving down the line, when the
kidney keeps being rejected by patients with lower queue priority and lower acceptance
standards, negative quality inference escalates. However, as more patients reject partly
because their predecessors have done so, refusals become less informative. Consequently,
observational learning slows down again near the end of the queue.
The impact of acceptance standards on quality inference calls for rethinking of the
conventional need-based allocation mechanisms for scarce resources. By giving priority
to people with the most need, efficiency is enhanced conditional on acceptance. However,
in the possible case of refusal despite urgent need, others may draw strongly negative
quality inferences which slow down the utilization of scarce resources.
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5 Counterfactual Simulations of Alternative Learning Mecha-
nisms
In this section, we use parameter estimates obtained from the observational learning
model to simulate patients’ kidney acceptance decisions under two counterfactual learning
mechanisms. One is if there were no social learning and each patient only followed her
private signal. The other is if each patient were able to share the private signals of
all her predecessors. We then compare the decision quality of these mechanisms and
observational learning.
We make 10,000 random draws from the distribution of unobservable kidney qual-
ity, and match each up with one random draw of observable kidney attributes from the
data. Each simulated kidney draw is assigned a queue of eligible patients based on the
UNOS point system. These patients then receive independent private signals conditional
on the draw of unobservable kidney quality. Finally, each decision is assigned a ran-
dom idiosyncratic utility shock. We use the “first best” case of complete information
as the benchmark to assess the decision quality of each learning mechanism. That is,
we define optimal patient decisions as those dictated by true kidney quality, assuming it
is observable to patients. We then simulate patients’ decisions under different learning
mechanisms.
We first compare the prescriptive accuracy of these learning mechanisms. We define
“hit rate” as the percentage of decisions consistent with those indicated by complete
information, assuming each patient has the choice over each kidney.12 Information sharing
achieves a hit rate of 97.26%, higher than the 89.10% with observational learning (p =
0.000), which in turn is higher than the 88.17% without social learning (p = 0.000).
Out of all decisions, the percentage of type I errors, where a patient rejects a kidney
while complete information prescribes acceptance, is 10.08% with observational learning,
12Alternatively, we can remove a simulated kidney draw from the queue once it is accepted. However,
this may lead to biased measures of decision accuracy. For example, suppose complete information
indicates that a kidney is accepted at position 20, while observational learning delays acceptance until
position 40. If we truncate the queue after position 20, it will appear that observational learning achievers
a hit rate of 95%, which can be an overstatement because any decision mistakes after position 20 are not
captured.
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3.89% without social learning, and 1.33% with information sharing. The percentage of
type II errors, where a patient accepts a kidney while complete information prescribes
rejection, is 7.94% without social learning, 1.41% with information sharing, and 0.82%
with observational learning.
One limitation of hit rate is that it does not measure the valence of decision mistakes.
Also, since the above hit rate analysis is conditional on each patient receiving the current
kidney offer, it does not capture the possibility that better kidneys might have been
accepted early in the queue. To address both problems, we study patients’ ex ante
expected utility under different learning mechanisms. For each learning mechanism, a
kidney is removed from the queue once it is accepted. If a patient accepts a simulated
kidney offer, she earns the acceptance utility based on true kidney quality; if she rejects
an offer or does not receive one, she earns the discounted value of her future expected
utility net of waiting costs, taking her transition probabilities into account. The average
of a patient’s utility (given her choice and offer status) across simulated kidney draws
yields the ex ante expected utility of this patient for this learning mechanism.
Figure 5 plots patients’ average ex ante expected utility across queue positions. Gen-
erally, patients’ ex ante expected utility decreases along the queue, as good kidneys are
less likely to reach the back of the line. The only exception is in position one. Be-
cause some patients are advanced to the top due to perfect tissue match with the current
kidney, they are not guaranteed the same priority when the next kidney arrives. These
patients therefore enjoy lower rejection utilities, which in turn reduces the average ex ante
expected utility at the top of the queue. Among the three learning mechanisms, infor-
mation sharing generates the highest expected utility. In fact, the expected utility curve
with information sharing is almost identical to that with complete information. Patients
are worse off with observational learning, and are the worst off without social learning.13
As a measure of aggregate patient welfare, the total ex ante expected utility across all
patients is 102.641 with complete information, 102.179 with information sharing, 88.550
with observational learning, and 64.911 without social learning. The difference in average
13Importantly, in simulating decisions without social learning, we assume that patients know their
positions in the queue. That is, although patients judge the quality of the current kidney offer as if they
were first in the queue, they rationally know that in future they are less likely to receive good kidneys
if they are far down the line. Alternatively, if patients na¨ıvely believe that they will be the first in the
queue in future, they may overestimate their ex ante expected utility.
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ex ante expected utility is insignificant between complete information and information
sharing (p = 0.191), but significant between all other learning mechanisms (p = 0.000).
The best decision quality generated by information sharing is anticipated because it
represents the most informative mechanism among the three. With observational learn-
ing, patients also draw information from previous rejections. However, repeated observa-
tions of rejections may bias quality inferences downwards. This explains the frequent type
I decision errors with observational learning. Without social learning, patients further
ignore the information contained in previous rejections. In particular, patients ignore the
fact that good kidneys are ex ante less likely to remain available. As a result, they make
frequent type II decision errors.
An imperative of organ allocation in the U.S. is to improve the usage efficiency of
kidneys. The dominant problem is the high volume of type I decision errors, where “most
of the refused kidneys are of acceptable clinical value.” The policy experiments suggest
that facilitating information sharing among patients can help achieve this goal. A plat-
form could be set up where patients exchange their concerns for turning down the kidney
offer, should confidentiality regulations permit. This enhanced decision transparency can
limit over-interpretation of previous refusals, and prevent excessive rejections down the
line. Note that although suppressing social learning also increases acceptance, it creates
the opposite problem of overusing low quality kidneys. Whether organ allocation author-
ities should suppress social learning (for example, by offering kidneys simultaneously to a
batch of patients) depends on whether they aim to maximize kidney usage or maximize
aggregate patient utility.
6 Discussion: Implications for Other Markets
This paper models and finds evidence of observational learning from the kidney market.
The results bear direct relevance to other markets of single non-divisible goods which
can be consumed by a single buyer. Examples include labor markets, housing markets,
auctions, business-to-business contracting, journal publications, child adoptions, and mar-
riages. In these markets, mere “availability” signals lesser quality, although the signal
may be exaggerated. Credibly communicating the reasons behind availability facilitates
future transactions. In particular, marketers of these goods may want to emphasize it if
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availability is caused by non-quality reasons such as stringent adoption standards, taste
mismatch, high prices, and circumstantial restrictions.
More generally, observational learning affects choices if peer decisions convey relevant
quality information. This paper highlights the critical difference between observational
learning and information sharing (for example, through truthful word-of-mouth commu-
nication) in shaping choices. As two major ways of social learning, observational learning
and information sharing are often intertwined in practice with their effects studied in
combination. For example, most diffusion models focus on forecasting product adoption
paths that are jointly fueled by observations and communications (e.g., Bass 1969, Horsky
and Simon 1983, Narasimhan 1989, Talukdar, Sudhir and Ainslie 2002, Golder and Tellis
2004). It is therefore often unclear which force is the main driver of sales and what the
optimal marketing strategies should be. This paper suggests two aggregate predictions
that differentiate observational learning and information sharing in general marketplaces.
First, if consumers’ private information collectively reveals the true value of a product,
information sharing as a signal averaging mechanism will ensure that the ultimate success
of a product reflects its quality. If choices are instead driven by observational learning,
mass behavior can sometimes depart from what the underlying values would prescribe. As
a result, the quality of popular products may turn out to be surprisingly low. For example,
one major criticism of today’s user-moderated web sites such as Digg.com is that stories
promoted to the front page for their popularity are frequently found to carry poor content.
Indeed, hits and misses can crucially depend on how the product is initially received by
the market. The business book The Discipline of Market Leaders is believed to have
made the bestseller list despite lackluster reviews because the authors secretly bought
back 50,000 copies at book release (Bikhchandani, Hirshleifer and Welch 1998). Beyond
the ethical debate surrounding such promotional tactics, a general message to marketers
is that the early stage can be critical in shaping a product’s life cycle, especially in
categories such as apparel, automobile, and digital music where choices are highly visible.
For these categories, the impact of observational learning should be factored into dynamic
marketing decisions such as advertising timing, introductory pricing, and targeting.
Second, market dynamics under observational learning can be sensitive to the choices
of a few pivotal consumers. While diffusion paths driven by information sharing tend to
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follow a smooth trajectory, those shaped by observational learning can be turbulent with
abrupt changes in mass behavior triggered by small events. It is likely, for example, that
observational learning has powered the unanticipated rejuvenation of Hush Puppies in the
mid 1990s, the sudden rave of text messaging despite little promotion, and the whimsical
rise and fall of fashion ideals. While injecting significant unpredictability into the market,
observational learning also offers marketers ample opportunities to orchestrate large-scale
changes with a limited budget. For example, marketing resources spent on marginal
customers and visible users may bring disproportionate returns to the firm, although the
exact amount of returns depends on how consumers strategically react to such marketing
tactics.
7 Concluding Remarks
Mere observation of others’ choices can be a quality signal. This paper studies observa-
tional learning in the U.S. deceased-donor kidney market, where transplant candidates on
a waiting list sequentially decide whether to accept a kidney offer. The fact that a patient
receives a kidney offer implies that all patients before her in the queue have turned down
the same kidney. However, confidentiality does not allow between-patient communication
of the reasons for the refusals.
We model observational learning at the patient level. Kidney quality is not perfectly
observed. However, each patient has private information on kidney quality, such as her
doctor’s opinion. Suppose the second patient is offered a kidney. She can infer that the
first patient’s private signal is not favorable enough. She then uses this information and
her private signal to update her quality perception following Bayes’ rule. Without sharing
the exact concerns, the first patient’s refusal can only (weakly) lower the second patient’s
inferred quality, thus increasing her probability of refusal as well. Consequently, refusals
can be self-reinforcing, causing an otherwise acceptable kidney to be wasted.
The data shows aggregate patterns consistent with observational learning. Even iden-
tical same-donor kidneys are received much differently; some of them are accepted early
on in the queue while their identical counterparts have to travel far down the line to find
a willing recipient. At the same time, the U.S. kidney allocation organizations lament
the poor kidney acceptance rate which is lower than what the observable patient and
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kidney characteristics could justify. We estimate the observational learning model using
disaggregate data, controlling for patient-donor match, deterioration of kidney quality
while traveling down the line, unobservable (to the researcher) kidney quality informa-
tion, patients’ risk attitudes and prospects of future kidney offers. We find evidence of
observational learning, where inferred quality indeed declines towards the back of the
queue. We then simulate patient choices in two counterfactual scenarios, one without
social learning, and the other with information sharing. Patients make more efficient
decisions with information sharing, and worse decisions without social learning. The
findings suggest that facilitating communication among patients can help improve kidney
utilization.
A general message to marketers is that mass behavior can be shaped by the choices of
a few. Therefore, how to manage observational learning to marketers’ benefits becomes
an important managerial question, especially in markets where choices are immediately
visible while information sharing lags behind. Early adopters, visible lead users, and
marginal consumers can all be critical determinants of product success.
This study suggests a way to model observational learning in the field. Technically,
observational learning becomes relevant when decisions are at least partially sequential
and are not sufficient statistics of decision-makers’ private information (Banerjee 1992).
Below we discuss several possibilities of extending the observational learning model to
more complex marketplaces.
First, decisions may not always be sequential. The pace of learning will vary with
the timing of decisions. For example, suppose a new laptop model has achieved success
among technology enthusiasts who make independent purchase decisions. The rest of the
population can then infer higher quality than if the early wave itself was formed through
observational learning. In other words, by delaying observational learning, marketers
may subsequently create a fast rising herd. The optimal timing to enable observational
learning would be interesting to explore, given that timing itself can signal quality.
Second, in general markets observational learning may drive the herd in both ways.
Product success is path-dependent rather than a simple sum of per-period sales. For
example, declining sales following an early rave communicates a different quality image
than delayed popularity following a slow start. The model we present can be extended
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to accommodate any permutation of adoption/rejection decisions along the sequence.
An interesting question remains though on how marketers should allocate promotional
resources across time, given strategic consumer reactions.
Third, it is often uncertain how many people have actually made a decision. For
example, a consumer may not know whether sluggish sales is due to lack of awareness
or lack of preference. This is analogous to the “attribution story” of the kidney market,
where a patient may not know whether a refusal is due to mismatch or a poor signal.
Future studies can model awareness as a moderator of quality inferences and a strategic
marketing decision variable.
Last but not least, observational learning often coexists with information sharing
(Chen, Wang, and Xie 2009). It would be important to understand how they interact.
Also, it would be interesting to distinguish between observational learning and simple
mimicking, which may generate similar behavior although they represent distinct behav-
ioral mechanisms.
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8 Appendix
8.1 The Queue Construction Process
UNOS oversees 90 organ procurement organizations (OPOs) throughout the United States.
An OPO is an organization which concentrates its organ procurement efforts within a geo-
graphic territory. When a kidney is procured by an OPO, blood-type compatible patients
within this OPO are selected and sorted into a queue based on a point system that UNOS
launched in 1995.14 Specifically, the UNOS point system constructs the queues based on
the following four criteria. First, priority is given to patients with longer waiting time. A
patient receives 1 point for each year spent on the waiting list. Second, priority is given to
patients who have better tissue match with the donor. The tissue type is determined by
six proteins at six loci, namely, A1, A2, B1, B2, DR1 and DR2. A “mismatch” occurs at
a locus if the patient and the donor have different protein types there. A patient receives
infinite points if there is no mismatch at any of the six loci (perfect tissue match), 2
points if there is no mismatch at the DR loci (second-best tissue match), and 1 point if
there is one mismatch at the DR loci (third-best tissue match). Third, priority is given
to patients with higher peak panel reactive antibody (PRA) measures, who are subject
to higher risk of graft failure. Peak PRA ranges between 0 and 1. 4 points are given
to patients whose peak PRA are greater than 80%. Fourth, priority is given to patients
below 18 years of age who have higher risk of graft failure. Patients below 11 receive 4
points, and those between 11 and 18 get 3 points.
For each kidney, eligible patients are ranked in descending order of total UNOS points.
In practice, the continued shortage of kidneys has lengthened the average waiting time,
making it the dominant factor in determining the queue. Meanwhile, only a small fraction
of patients qualify for criteria two to four. (See Table 1 for the percentages in the sample of
this study.) As a result, the UNOS point scheme is converging to a first-come-first-served
priority system (Su and Zenios 2004). In this data, patients’ current queue position and
next-period queue position are significantly positively correlated (ρ = .803, p = .000).
14A small fraction of patients register at multiple OPOs. According to the UNOS 2002 Annual Report,
5.74% of patients on the national waiting list sign up with two OPOs, 0.30% sign up with three, 0.02%
four, and none above four. This study does not model multiple registration, but treats each OPO as one
separate waiting list.
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8.2 Formulating the Simulated Log-likelihood Function
The log-likelihood function involves high dimensional integrals. First of all, the cutoff
sequence {Bit} is only stochastically known to subsequent patients. Therefore, to form
her quality inference, a patient needs to evaluate Equation 3.12 by integrating over the
joint distribution G(B1t, · · · , Br−1,t). We approximate this integral by taking N random
draws from the joint distribution of B1t, · · · , Br−1,t, evaluating the integrand at these
draws, and taking the mathematical average:
1
N
N∑
n=1
r−1∏
j=1
Φ(
Bnjt − θt
σs
)
where Bnjt is obtained by solving patient j’s indifference condition (Equation 3.13) given
an nth draw from the joint distribution of Xjt, Zjt, jt and jot. (Technical details on how
to solve the cutoff sequence recursively are available upon request.) Note that the cutoff
sequence only depends on the joint distribution of patient and kidney characteristics
and idiosyncratic utility shocks, but not on the actual signals. Therefore, {Bit} can be
solved recursively independent of {sit}. This property allows us to perform simulation in
separate modules: the total number of simulation draws needed to form the log-likelihood
is linear in, rather than multiplicative of, the number of signal draws and cutoff draws.
Given the random cutoff draws, the posterior expected quality with observational
learning, hrt, can be approximated as
hˆrt(srt,∆) =
1
D
∫
φ(
srt − θt
σs
) φ(
θt − µ
σθ
)
1
N
N∑
n=1
r−1∏
j=1
Φ(
Bnjt − θt
σs
) θt dθt
where
D =
∫
φ(
srt − θt
σs
) φ(
θt − µ
σθ
)
1
N
N∑
n=1
r−1∏
j=1
Φ(
Bnjt − θt
σs
) dθt
Evaluating hˆrt(srt,∆) involves one-dimensional integration over θt, which is numerically
implemented using Gaussian quadratures.
After knowing hˆrt(srt,∆), the expected utility and hence the probability for patient i
to accept kidney t can be calculated based on Equation 3.16. Denote this probability as
Pˆ r(dit = 1|sit,∆), which is a function of the draw of private signal sit and ∆. Last, to
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evaluate Pr(Rt|∆), the private signals need to be simulated:
Pˆ r(Rt|∆) = 1
L
L∑
l=1
{
Rt−1∏
i=1
[
1
M
M∑
m=1
(1− Pˆ r(dit = 1|slmit ,∆))]
1
M
M∑
m=1
Pˆ r(dRt,t = 1|slmRt,t,∆)}
The specific procedure is to make L random draws from the distribution of θt for each
kidney t. Label the lth draw θlt. Given each θ
l
t, the private signals are conditionally
independent. Let eit denote the deviation of actual signal sit from θ
l
t. eit follows an i.i.d.
normal distribution with mean 0 and variance σ2s . Make M draws from the distribution
of eit and label the m
th draw emit . It follows that s
lm
it = θ
l
t+ e
m
it . This procedure maintains
the signal correlation for the same kidney.
Finally, the simulated log-likelihood function to maximize is
LˆL(∆) =
T∑
t=1
ln Pˆ r(Rt|∆)
40
9 References
Anderson, Eric T., and Duncan I. Simester (2001), “Price Discrimination as an Adverse Signal:
Why an Offer to Spread Payments May Hurt Demand,” Marketing Science, 20(3), 315-327.
Anderson, Lisa R., and Charles A. Holt (1997), “Information Cascades in the Laboratory,”
American Economic Review, 87:5, 847-862.
Banerjee, Abhijit V. (1992), “A Simple Model of Herd Behavior,” Quarterly Journal of Eco-
nomics, Vol. 107, Issue 3, 797-817.
Bass, Frank M. (1969), “A New Product Growth Model For Consumer Durables,” Management
Science, 15(5), 215-227.
Bikhchandani, Sushil, David Hirshleifer, and Ivo Welch (1992), “A Theory of Fads, Fashion,
Custom, and Cultural Changes as Information Cascades,” Journal of Political Economy, Vol.
100, No. 5, 992-1026.
——— (1998), “Learning from the Behavior of Others: Conformity, Fads, and Informational
Cascades,” Journal of Economic Perspectives, 12(3), 151-171
Camerer, Colin, and Teck-Hua Ho (1999), “Experienced-Weighted Attraction Learning in Nor-
mal Form Games,” Econometrica, 67(4), 827-874.
C¸elen, Bogˇac¸han, and Shachar Kariv (2004), “Distinguishing Informational Cascades from Herd
Behavior in the Laboratory,” American Economic Review, 94(3), 484-497.
Chen, Yubo, Qi Wang, and Jinhong Xie (2009), “Online Social Interactions: A Natural Exper-
iment on Word of Mouth versus Observational Learning,” working paper.
Chintagunta, Pradeep K., Tu¨lin Erdem, Peter E. Rossi, and Michel Wedel (2006), “Structural
Modeling in Marketing: Review and Assessment,” Marketing Science, 25(6), 604-616.
Coleman, James S., Elihu Katz, and Herbert Menzel (1966), Medical Innovation: A Diffusion
Study. Indianapolis: Bobbs-Merrill.
Coscelli, Andrea, and Matthew Shum (2004), “An Empirical Model of Learning and Patient
Spillovers in New Drug Entry,” Journal of Econometrics, 122(2), 213-246.
DeGroot, Morris H. (1970), Optimal Statistical Decisions, New York: McGraw-Hill.
Desai, Preyas S. (2000), “Multiple Messages to Retain Retailers: Signaling New Product De-
mand,” Marketing Science, 19(4), 381-389.
41
Ellison, Glenn, and Drew Fudenberg (1995), “Word-of-Mouth Communication and Social Learn-
ing,” Quarterly Journal of Economics, 110, 93-125.
Erdem, Tu¨lin, and Michael P. Keane (1996), “Decision-Making Under Uncertainty: Capturing
Dynamic Brand Choice Processes in Turbulent Consumer Goods Markets,” Marketing Science,
15(1), 1-20.
Godes, David, and Dina Mayzlin (2004), “Using Online Conversations to Measure Word of
Mouth Communications,” Marketing Science, 23(4), 545-560.
Golder, Peter N., and Gerard J. Tellis (2004), “Growing, Growing, Gone: Cascades, Diffusion,
and Turning Points in the Product Life Cycle,” Marketing Science, 23(2), 207-218.
Guo, Liang, and Ying Zhao (2008), “Voluntary Quality Disclosure and Market Interaction,”
Marketing Science, forthcoming.
Hitsch, Gu¨nter J. (2006), “An Empirical Model of Optimal Dynamic Product Launch and Exit
Under Demand Uncertainty,” Marketing Science, 25(1), 25-50.
Horsky, Dan, and Leonard S. Simon (1983), “Advertising and the diffusion of New Products,”
Marketing Science, 2(1), 1-17.
Kuksov, Dmitri (2007), “Brand Value in Social Interaction,”Management Science, 53(10), 1634-
1644.
Manchanda, Puneet, Ying Xie, and Nara Youn (2008), “The Role of Targeted Communication
and Contagion in Product Adoption,” Marketing Science, 27(6), 961-976.
Manski, Charles F. (1993), “Identification of Endogenous Social Effects: The Reflection Prob-
lem,” Review of Economic Studies, 60(3), 531-542.
Mayzlin, Dina (2006), “Promotional Chat on the Internet,” Marketing Science, 25(2), 155-163.
Moorthy, Sridhar, and Kannan Srinivasan (1995), “Signaling Quality with a Money-Back Guar-
antee: The Role of Transaction Costs,” Marketing Science, 14(4), 442-466.
Nair, Harikesh, Pradeep Chintagunta and Jean-Pierre Dube´ (2004), “Empirical Analysis of
Indirect Network Effects in the Market for Personal Digital Assistants,” Quantitative Marketing
and Economics, 2(1), 23-58.
Narasimhan, Chakravarthi (1989), “Incorporating Consumer Price Expectations in Diffusion
Models,” Marketing Science, 8(4), 343-357.
Narayanan, Sridhar, Pradeep K. Chintagunta, and Eugenio J. Miravete (2007), “The Role of
42
Self Selection, Usage Uncertainty and Learning in the Demand for Local Telephone Service,”
Quantitative Marketing and Economics, 5(1), 1-34.
Nelson, Phillip (1970), “Information and Consumer Behaviour,” Journal of Political Economy,
94, 796-821.
OPTN/SRTR (2006), 2006 Annual Report of the U.S. Organ Procurement and Transplanta-
tion Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996-2005,
Health Resources and Services Administration, Healthcare Systems Bureau, Division of Trans-
plantation, Rockville, MD.
Roth, Alvin E., Tayfun So¨nmez, and M. Utku U¨nver (2004), “Kidney Exchange,” Quarterly
Journal of Economics, 119 (2), 457-488.
Rust, John (1987), “Optimal Replacement of GMC Bus Engines: An Empirical Model of Harold
Zurcher,” Econometrica, 55(5), 999-1033.
Su, Xuanming, and Stefanos A. Zenios (2004), “Patient Choice in Kidney Allocation: The Role
of the Queueing Discipline,” Manufacturing and Service Operations Management, 6(4), 280-301.
Su, Xuanming, Stefanos A. Zenios, and Glenn M. Chertow (2004), “Incorporating Recipient
Choice in Kidney Transplantation,” Journal of the American Society of Nephrology, 15, 1656-
1663.
Sun, Baohong, Jinhong Xie, and H. Henry Cao (2004), “Product Strategy for Innovators in
Markets with Network Effects,” Marketing Science, 23(2), 243-254.
Talukdar, Debabrata, K. Sudhir, and Andrew Ainslie (2002), “Investigating New Product Dif-
fusion,” Marketing Science, 21(1), 97-114.
United Network for Organ Sharing (2002), UNOS 2002 Annual Report of the US Scientific
Registry of Transplant Recipients and the Organ Procurement and Transplantation Network:
Transplant Data 1992-2001, Rockville, MD.
U.S. Renal Data System (2001), USRDS 2001 Annual Data Report: Atlas of End-Stage Renal
Disease in the United States, National Institutes of Health, National Institute of Diabetes and
Digestive and Kidney Diseases, Bethesda, MD.
Van den Bulte, Christophe, and Gary L. Lilien (2001), “Medical Innovation Revisited: Social
Contagion versus Marketing Effort,” American Journal of Sociology, 106:5, 1409-1435.
Villas-Boas, J. Miguel, and Russell S. Winer (1999), “Endogeneity in Brand Choice Models,”
43
Management Science, 45(10), 1324-1338.
Villas-Boas, J. Miguel (2004), “Consumer Learning, Brand Loyalty, and Competition,” Market-
ing Science, 23(1), 134-145.
Villas-Boas, J. Miguel (2006), “Dynamic Competition with Experience Goods,” Journal of
Economics and Management Strategy, 15(1), 37-66.
Wernerfelt, Birger (1995), “A Rational Reconstruction of the Compromise Effect: Using Market
Data to Infer Utilities,” The Journal of Consumer Research, 21(4), 627-633.
Yang, Sha, and Greg M. Allenby (2003), “Modeling Interdependent Consumer Preferences,”
Journal of Marketing Research, Vol. XL (August), 282-294.
44
Table 1: Summary Statistics
Patient-specific variables (N=338)
Variable Mean Std. Dev. Min Max
Patient age 47.059 14.342 4 79
Patient age =< 11* 0.018 0.132 0 1
11 < Patient age =< 18* 0.018 0.132 0 1
Patient_female* 0.340 0.474 0 1
Patient_Caucasian* 0.790 0.408 0 1
Patient_unemployed* 0.559 0.497 0 1
Income ($1,000) 30.733 11.789 6.399 86.254
PRA > 80%* 0.018 0.132 0 1
# Years on dialysis 1.649 2.025 0 13
Kidney-specific variables (N=275)
Variable Mean Std. Dev. Min Max
Donor age 32.186 15.483 0 73
Donor_female* 0.447 0.498 0 1
Donor_Caucasian* 0.895 0.308 0 1
Accepting patient: position in queue 34.124 19.406 1 77
Accepting patient: # previous offers 15.455 23.994 0 166
Accepting patient: # days waiting 209.440 206.311 1 1272
Patient-kidney interactive variables (N=9384)
Variable Mean Std. Dev. Min Max
0 mismatch* 0.004 0.059 0 1
0 mismatch at DR* 0.038 0.190 0 1
1 mismatch at DR* 0.406 0.491 0 1
Cold time 8.877 7.034 0.016 43
Accept* 0.029 0.169 0 1
* dummy variable which equals 1 if the statement in the variable name is true, and 0 otherwise
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Table 2: Estimation Results
      
 No Quality Public  No Social Information Observational 
Parameters Uncertainty Information Learning Sharing Learning 
 
(α = 0 ) ( sσ = 0) 
      
Intercept 0.000  -0.001  -0.001  -0.001  0.000  
Patient Age 0.023 ** 0.023 ** 0.023 ** 0.016 ** 0.015 ** 
Patient_Female 0.008  0.018  0.027  0.019  0.009  
Patient_Caucasian -0.245  -0.205  -0.194  -0.283  -0.284  
Patient Income 0.000  0.000  0.000  0.000  0.000  
Patient_Unemployed -0.026  -0.006  -0.002  -0.007  -0.039  
# Years on Dialysis  -0.014  -0.002  0.000  -0.002  -0.008  
PRA > 80% -0.784  -0.317  -0.284  -0.273  -0.491  
Patient Below 11 0.935  0.976  0.991  0.919  0.920  
Patient Bw 11 & 18 1.325  1.209  1.218  1.278  0.726  
Donor Age 0.000  0.000  0.000  0.000  0.000  
Donor_Female 0.159  0.127  0.118  0.043  0.053  
Donor_Caucasian -0.142  -0.113  -0.096  -0.127  -0.284  
0 Mismatch 6.396 **** 6.838 **** 6.832 **** 6.858 **** 6.004 **** 
0 Mismatch at DR 1.487 **** 1.462 *** 1.441 *** 1.956 *** 1.474 *** 
1 Mismatch at DR   0.186  0.158  0.144  0.630  0.442 * 
Cold Time 0.075 ** 0.078 ** 0.078 ** 0.093 ** 0.104 ** 
Utility Weight on Unobs. α  ----  0.001 ** 0.003 ** 0.172 ** 2.260 **** 
Signal Noise sσ  ----  ----  0.000  0.208 ** 0.524 **** 
Risk Coefficient ρ  
----   ----   0  ---- -0.011 * 0.003   
# Observations 9384  9384  9384  9384  9384  
# Parameters 17  18  19  20  20  
LL -913.732  -911.513  -911.397  -908.323  -897.931  
AIC 1861.464  1859.026  1860.794  1856.646  1835.862  
           
 
* P < 0.10 ** P < 0.05 *** P < 0.01 **** P < 0.001 
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Figure 3: Quality Inference—Example of One Kidney
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Figure 4: Quality Inference—Aggregate Effect
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Figure 5: Policy Experiments: Patients’ Ex Ante Expected Utility
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